Picture of Fresenius SE & Co. KGaA logo

FRE — Fresenius SE & Co. KGaA News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareConservativeLarge CapNeutral

Brief: Fresenius: Receives FDA Approval For Denosumab Biosimilars

March 27 (Reuters) - FRESENIUS SE & CO KGAA FREG.DE:

FDA APPROVAL FOR THEIR DENOSUMAB BIOSIMILARS AND SECURES GLOBAL SETTLEMENT AGREEMENT

Further company coverage: FREG.DE

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Fresenius SE & Co. KGaA

See all news